This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Garth L. Nicolson, PhD
The University of Texas M. D. Anderson Cancer Center Houston

Nancy L. Rosenberg-Nicolson, PhD
Rhodon Foundation for Biomedical Research Kingwood, Tex

JAMA. 1995;273(8):618-619.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—If the National Institutes of Health (NIH) Technology Assessment Workshop report on Operation Desert Storm syndrome/illnesses was meant to address fears that these illnesses are not being taken seriously and to establish practical working case definitions for the chronic illnesses associated with Operations Desert Shield and Desert Storm, it was not an auspicious start. After listening to the health complaints of numerous veterans of Operations Desert Shield and Desert Storm, including our stepdaughter and her colleagues who served in the US Army's 101st Airborne Division, and complaints about their inability to convince military hospitals and Veterans Affairs medical centers that they are suffering from a possible syndrome with the same major symptoms listed in the workshop report, we attempted to suggest that many of these symptoms can be explained by aggressive pathogenic mycoplasma infections, such as Mycoplasma incognitus or Mycoplasma penetrans,² and they should be treatable . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?